1. Home
  2. ATNI vs CGC Comparison

ATNI vs CGC Comparison

Compare ATNI & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ATN International Inc.

ATNI

ATN International Inc.

HOLD

Current Price

$32.60

Market Cap

415.7M

ML Signal

HOLD

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

HOLD

Current Price

$0.96

Market Cap

401.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATNI
CGC
Founded
1987
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Telecommunications Equipment
Pharmaceuticals and Biotechnology
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
415.7M
401.0M
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
ATNI
CGC
Price
$32.60
$0.96
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
N/A
AVG Volume (30 Days)
67.9K
2.1M
Earning Date
05-06-2026
05-29-2026
Dividend Yield
4.03%
N/A
EPS Growth
34.29
84.17
EPS
N/A
N/A
Revenue
$727,975,000.00
$12,759,000.00
Revenue This Year
$3.12
$8.27
Revenue Next Year
$1.10
$15.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.86
$0.84
52 Week High
$32.28
$2.38

Technical Indicators

Market Signals
Indicator
ATNI
CGC
Relative Strength Index (RSI) 76.11 58.99
Support Level $25.03 $0.98
Resistance Level N/A $1.08
Average True Range (ATR) 1.06 0.04
MACD 1.06 0.01
Stochastic Oscillator 96.66 78.32

Price Performance

Historical Comparison
ATNI
CGC

About ATNI ATN International Inc.

ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Share on Social Networks: